M. Selzner et al., Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer, CANCER RES, 61(3), 2001, pp. 1233-1240
Dysfunction in the physiological pathways of programmed cell death may prom
ote proliferation of malignant tells, and correction of such defects may se
lectively induce apoptosis in cancer cells. We measured the levels of ceram
ide, a candidate lipid mediator of apoptosis, in human metastatic colorecta
l cancer and tested in vitro and in vivo effects of various ceramide analog
ues in inducing apoptosis in metastatic colon cancer. Human colon cancer sh
owed a >50% decrease in the cellular content of ceramide when compared with
normal colon mucosa, Application of ceramide analogues and ceramidase inhi
bitors induced rapid cell death through activation of various proapoptotic
molecules, such as caspases and release of cytochrome c, Ceramidase inhibit
ion increases the ceramide content of tumor cells, resulting in maximum act
ivation of the apoptotic cascade. Normal liver cells were completely resist
ant to inhibitors of ceramidases, Treatment of nude mice with B13, the most
potent ceramidase inhibitor, completely prevented tumor growth using two d
ifferent aggressive human colon cancer cell lines metastatic to the liver.
Therefore, B13 and related analogues of ceramide and inhibitors of ceramida
ses offer a promising therapeutic strategy with selective toxicity toward m
alignant but not normal cells. These studies also suggest that the ceramide
content in cancer cells might be involved in the pathogenesis of tumor gro
wth in vitro and in vivo.